Panisset M - Search Results

1

Deep Brain Stimulation Target Selection for Parkinson's Disease.

Honey CR, Hamani C, Kalia SK, Sankar T, Picillo M, Munhoz RP, Fasano A, Panisset M. Honey CR, et al. Among authors: panisset m. Can J Neurol Sci. 2017 Jan;44(1):3-8. doi: 10.1017/cjn.2016.22. Epub 2016 Mar 15. Can J Neurol Sci. 2017. PMID: 26976064 Review.

2

Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and Dystonia.

Munhoz RP, Picillo M, Fox SH, Bruno V, Panisset M, Honey CR, Fasano A. Munhoz RP, et al. Among authors: panisset m. Can J Neurol Sci. 2016 Jul;43(4):462-71. doi: 10.1017/cjn.2016.35. Epub 2016 May 3. Can J Neurol Sci. 2016. PMID: 27139127 Review.

3

Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation.

Fasano A, Appel-Cresswell S, Jog M, Zurowkski M, Duff-Canning S, Cohn M, Picillo M, Honey CR, Panisset M, Munhoz RP. Fasano A, et al. Among authors: panisset m. Can J Neurol Sci. 2016 Sep;43(5):626-34. doi: 10.1017/cjn.2016.274. Can J Neurol Sci. 2016. PMID: 27670207 Review.

4

Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada.

Panisset M, Picillo M, Jodoin N, Poon YY, Valencia-Mizrachi A, Fasano A, Munhoz R, Honey CR. Panisset M, et al. Can J Neurol Sci. 2017 Mar;44(2):132-138. doi: 10.1017/cjn.2016.409. Epub 2016 Nov 22. Can J Neurol Sci. 2017. PMID: 27873569

5

Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation.

Berney A, Panisset M, Sadikot AF, Ptito A, Dagher A, Fraraccio M, Savard G, Pell M, Benkelfat C. Berney A, et al. Among authors: panisset m. Mov Disord. 2007 Jun 15;22(8):1093-6. doi: 10.1002/mds.21245. Mov Disord. 2007. PMID: 17394245

6

Open-Label Study of Sleep Disturbances in Patients with Parkinson's Disease Treated with Rasagiline.

Panisset M, Stril JL, Bélanger M, Lehoux G, Coffin D, Chouinard S. Panisset M, et al. Can J Neurol Sci. 2016 Nov;43(6):809-814. doi: 10.1017/cjn.2016.289. Can J Neurol Sci. 2016. PMID: 27827298

7

Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson's Disease.

Law C, Chriqui E, Kergoat MJ, Leclerc BS, Panisset M, Irving EL, Postuma RB, Chouinard S, Kergoat H. Law C, et al. Among authors: panisset m. Can J Neurol Sci. 2017 Sep;44(5):562-566. doi: 10.1017/cjn.2017.39. Can J Neurol Sci. 2017. PMID: 28862105

8

Physical activity in advanced Parkinson's disease: impact of subthalamic deep brain stimulation.

Daneault JF, Sadikot AF, Barbat-Artigas S, Aubertin-Leheudre M, Jodoin N, Panisset M, Duval C. Daneault JF, et al. Among authors: panisset m. J Parkinsons Dis. 2015;5(1):85-93. doi: 10.3233/JPD-140426. J Parkinsons Dis. 2015. PMID: 25361545

9

Neurofilament M gene in a French-Canadian population with Parkinson's disease.

Han F, Bulman DE, Panisset M, Grimes DA. Han F, et al. Among authors: panisset m. Can J Neurol Sci. 2005 Feb;32(1):68-70. doi: 10.1017/s0317167100016905. Can J Neurol Sci. 2005. PMID: 15825549

10

LRRK2 screening in a Canadian Parkinson's disease cohort.

Grimes DA, Racacho L, Han F, Panisset M, Bulman DE. Grimes DA, et al. Among authors: panisset m. Can J Neurol Sci. 2007 Aug;34(3):336-8. doi: 10.1017/s0317167100006788. Can J Neurol Sci. 2007. PMID: 17803033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters